NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NYSE American · Medical Devices · USD

Catheter Precision, Inc. (VTAK) Stock Analysis

Catheter Precision, Inc. (VTAK) is a Medical Devices stock listed on NYSE American and quoted in US Dollar.

VTAK

$0.21

+$0.01 (+5.00%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare VTAK with… →

VTAK Key Statistics

As of Sep 4, 2026
Trading
Open
$0.19
Previous Close
$0.20
Day's Range
0.19–0.21
52-Week Range
0.19–3.20
Volume
879.50K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.47
Valuation
Market Cap
$757.99K
P/E Ratio
unprofitable
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
0.40
EPS (ttm)Profit attributable to each share over the last twelve months.
−4.07
Financials (FY)
Revenue (FY)
$819.00K+95.00%
Net Income (FY)
−$17.18M
Profit marginThe share of revenue left as profit after all costs and taxes.
0.00%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
3.61M
1-Year Return
−91.73%
Dividend and dates
Avg Volume
10.88M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

VTAK Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−88.52%
2025−78.60%
2024−88.75%
2023−93.21%
2022−92.45%
2021−79.00%
2020−73.70%
2019−85.79%
2018 (partial year)−60.25%

As of September 4, 2026.

VTAK Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$819.00K−$17.18M−2098.0%
2024$420.00K−$16.64M−3962.6%
2023$442.00K−$70.57M−15966.5%
2022$14.00K−$26.87M−191892.9%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$819.00K$756.00K−$12.18M−$17.18M−2098.0%
2024$420.00K$378.00K−$11.24M−$16.64M−3962.6%
2023$442.00K$412.00K−$17.19M−$70.57M−15966.5%
2022$14.00K−$147.00K−$22.79M−$26.87M−191892.9%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

VTAK Valuation vs Medical Devices Median

Median of 151 stocks
MetricVTAKMedical Devices medianvs median
P/S ratio0.402.980.1x the median
Profit margin0.00%−1.69%1.7 pts above

Medians across 151 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values Catheter Precision, Inc. (VTAK) at $757.99K. It is classified in the Medical Devices industry, within the Healthcare sector. Headcount on file is 17.

The 52-week range on file runs from $0.19 to $3.20. VTAK last closed at $0.21 on September 4, 2026. That is +$0.01 (+5.00%) against the previous close. The latest close sits 10.58% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $819.00K. Against the prior fiscal year total of $420.00K, that is a change of +95.00%. The same year closed with a net loss of $17.18M. Profit margin runs at 0%. That is 1.7 percentage points above the Medical Devices median of −1.69%. Earnings per share on a trailing basis come to −4.07.

Across the 4 fiscal years on file, revenue moves from $14.00K in 2022 to $819.00K in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. Measured against sales, the shares trade at 0.4 times revenue. On price-to-sales that is 0.1 times the Medical Devices median of 2.98. 151 Medical Devices companies report these metrics, and the medians quoted come from that group.

Over the trailing twelve months the price has returned −91.73%. Across 5 years the annualized return works out at −90.71%. Beta against the wider market is reported at 0.47. Annualized volatility over the trailing 7 years is 150.54%.

Growth & Income

No dividend is on file for VTAK.

Across the complete calendar years on file, 2020 returned −73.70% and 2023 returned −93.21%. Of the 7 complete calendar years on file, 0 finished higher. So far in 2026 the price is −88.52%.

Peer Comparison

Catheter Precision, Inc. (VTAK) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Catheter Precision, Inc. VTAK $757.99K —
Abbott Laboratories ABT $187.45B 35.1
Medtronic plc. MDT $120.46B 22.9
Stryker Corporation SYK $116.27B 31.9

The Medical Devices industry average P/E ratio is 26.8x. Catheter Precision, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$187.45B

 MDT

Medtronic plc.

$120.46B

 SYK

Stryker Corporation

$116.27B

 BSX

Boston Scientific Corporation

$69.27B

 EW

Edwards Lifesciences Corporation

$51.82B

 DXCM

DexCom, Inc.

$33.17B
View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About Catheter Precision, Inc.

Catheter Precision, Inc. designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States and Europe. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures; and LockeT, a suture retention device that temporarily secure sutures and aid clinicians in locating and removing sutures. Catheter Precision, Inc. was formerly known as Catheter Robotics Inc. The company is based in Fort Mill, South Carolina.

Visit website →